COR vs TROW · P/E 21, rev $321.33B vs P/E 12, rev $7.09B
Cencora Inc. (COR) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
COR currently screens at market cap $53.91B and trailing P/E 21.2. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the COR and TROW stock pages for the full models.
Not investment advice.